Actos Buyers Fight To Preserve Market-Exclusivity Suit
A proposed class of purchasers of diabetes drug Actos urged a New York federal judge Thursday to keep alive their suit claiming Takeda Pharmaceutical Company Ltd. misrepresented certain patents in an...To view the full article, register now.
Already a subscriber? Click here to view full article